Metastatic Adrenocortical Carcinoma to the Skin: A Case Report and Review of This Unusual Neoplasm

被引:0
作者
Lee-Diaz, Efrain [1 ]
Contreras, Carlo [2 ]
Plaza, Jose A. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr OSUWMC, Div Dermatopathol, Dept Pathol, Columbus, OH USA
[2] Ohio State Univ, Wexner Med Ctr OSUWMC, Dept Surg, Columbus, OH USA
关键词
adrenocortical carcinoma; cutaneous metastasis; metastatic carcinoma; ADRENAL-CORTICAL CARCINOMA; RENAL-CELL CARCINOMA; MELAN-A; DISTINCTION; INHIBIN; LESIONS; TUMORS; A103;
D O I
10.1097/DAD.0000000000002816
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Adrenocortical carcinoma is a very rare oncologic condition with poor prognosis that usually metastasizes to the lungs, liver, local lymph nodes, and peritoneum at initial presentation. However, skin metastasis is very uncommon and has rarely been reported even in advanced stages of the disease. We present a case of a 41-year-old man with a known history of adrenocortical carcinoma of the right adrenal gland that presented with an arm mass. The histopathologic sections showed a multinodular necrotic malignant neoplasm in dermis and subcutaneous fat composed of atypical epithelioid cells with ample granular cytoplasm and pleomorphic vesicular nuclei with frequent intranuclear inclusions and atypical mitoses. The immunohistochemical stains showed tumor cells that were strongly positive for synaptophysin and inhibin, only focally positive for Melan-A, and negative for AE1/AE3. The histopathologic features and the immunohistochemical profile confirmed the diagnosis of metastatic carcinoma consistent with adrenal cortical origin. The diagnosis can be difficult (especially when no clinical data are provided), and an immunohistochemical battery is often useful in distinguishing this tumor from other tumors with similar cytomorphological features.
引用
收藏
页码:696 / 699
页数:4
相关论文
共 33 条
  • [1] Prognostic parameters of metastatic adrenocortical carcinoma
    Assie, Guillaume
    Antoni, Guillemette
    Tissier, Frederique
    Caillou, Bernard
    Abiven, Gwenaelle
    Gicquel, Christine
    Leboulleux, Sophie
    Travagli, Jean-Paul
    Dromain, Clarisse
    Bertagna, Xavier
    Bertherat, Jerome
    Schlumberger, Martin
    Baudin, Eric
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) : 148 - 154
  • [2] Adrenocortical Carcinoma in the United States Treatment Utilization and Prognostic Factors
    Bilimoria, Karl Y.
    Shen, Wen T.
    Elaraj, Dina
    Bentrern, David J.
    Winchester, David J.
    Kebebew, Electron
    Sturgeon, Cord
    [J]. CANCER, 2008, 113 (11) : 3130 - 3136
  • [3] Brau-Javier CN, 2010, P R HEALTH SCI J, V29, P330
  • [4] The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity
    Chandrasekar, Thenappan
    Goldberg, Hanan
    Klaassen, Zachary
    Wallis, Christopher J. D.
    Woon, Dixon T. S.
    Herrera-Caceres, Jaime O.
    Kulkarni, Girish S.
    Fleshner, Neil E.
    [J]. CANCER, 2019, 125 (07) : 1050 - 1059
  • [5] Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates
    Duregon, Eleonora
    Volante, Marco
    Giorcelli, Jessica
    Terzolo, Massimo
    Lalli, Enzo
    Papotti, Mauro
    [J]. HUMAN PATHOLOGY, 2013, 44 (05) : 822 - 828
  • [6] Adrenocortical Carcinoma
    Else, Tobias
    Kim, Alex C.
    Sabolch, Aaron
    Raymond, Victoria M.
    Kandathil, Asha
    Caoili, Elaine M.
    Jolly, Shruti
    Miller, Barbra S.
    Giordano, Thomas J.
    Hammer, Gary D.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (02) : 282 - 326
  • [7] Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Fassnacht, M.
    Assie, G.
    Baudin, E.
    Eisenhofer, G.
    de la Fouchardiere, C.
    Haak, H. R.
    de Krijger, R.
    Porpiglia, F.
    Terzolo, M.
    Berruti, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (11) : 1476 - 1490
  • [8] Ghorab Z, 2003, APPL IMMUNOHISTO M M, V11, P330
  • [9] Hsing AW, 1996, INT J CANCER, V65, P432, DOI 10.1002/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO
  • [10] 2-Y